Study identifier:SD-039-0689
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Efficacy and safety of Symbicort (budesonide/ formoterol) 1280/36 mcg daily delivered dose compared to Pulmicort (budesonide) 1600 mcg metered dose and Pulmicort (budesonide) 1600 mcg metered dose plus Oxis (formoterol) 36 mcg delivered dose all delivered via Turbuhaler in steroid-using asthmatic adolescents and adults. A double-blind, double-dummy, randomized, parallel group, phase III, multicentre study.
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|